We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$396M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.28%
Holding
1,311
New
31
Increased
615
Reduced
268
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 59.19%
2 Technology 7.88%
3 Communication Services 4.43%
4 Consumer Discretionary 3.51%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
1076
DELISTED
Revance Therapeutics, Inc.
RVNC
$4K ﹤0.01%
141
DCPH
1077
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
107
RUBY
1078
DELISTED
Rubius Therapeutics, Inc
RUBY
$4K ﹤0.01%
178
GBT
1079
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4K ﹤0.01%
116
TBIO
1080
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$4K ﹤0.01%
140
ALEC icon
1081
Alector
ALEC
$168M
$3K ﹤0.01%
149
AMRN
1082
Amarin Corp
AMRN
$290M
$3K ﹤0.01%
36
ARQT icon
1083
Arcutis Biotherapeutics
ARQT
$3.48B
$3K ﹤0.01%
99
AUPH icon
1084
Aurinia Pharmaceuticals
AUPH
$1.96B
$3K ﹤0.01%
238
CDXS icon
1085
Codexis
CDXS
$141M
$3K ﹤0.01%
111
CYTK icon
1086
Cytokinetics
CYTK
$10.9B
$3K ﹤0.01%
133
GBIO
1087
DELISTED
Generation Bio
GBIO
$3K ﹤0.01%
11
INVA icon
1088
Innoviva
INVA
$1.57B
$3K ﹤0.01%
191
KRYS icon
1089
Krystal Biotech
KRYS
$10.4B
$3K ﹤0.01%
43
KURA icon
1090
Kura Oncology
KURA
$901M
$3K ﹤0.01%
131
MDGL icon
1091
Madrigal Pharmaceuticals
MDGL
$12.7B
$3K ﹤0.01%
29
MGNX icon
1092
MacroGenics
MGNX
$254M
$3K ﹤0.01%
106
PGEN icon
1093
Precigen
PGEN
$1.93B
$3K ﹤0.01%
401
QNCX icon
1094
Quince Therapeutics
QNCX
$17.5M
0
QURE icon
1095
uniQure
QURE
$2.63B
$3K ﹤0.01%
84
REPL icon
1096
Replimune Group
REPL
$724M
$3K ﹤0.01%
86
RGNX icon
1097
Regenxbio
RGNX
$622M
$3K ﹤0.01%
84
SGMO
1098
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3K ﹤0.01%
266
SUPN icon
1099
Supernus Pharmaceuticals
SUPN
$2.73B
$3K ﹤0.01%
99
TX icon
1100
Ternium
TX
$9.37B
$3K ﹤0.01%
+70
New +$2.67K

Similar funds

Daiwa Securities Group's Q2 2021 Portfolio in Review

As of Q2 2021, Daiwa Securities Group held 1,311 positions worth $14.8B, up 10% from $13.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q2 2021 filing shows 31 new, 615 increased, 268 reduced and 37 closed positions. Its largest new stake was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M. The largest sale was Invitation Homes, an estimated $172M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2021 buy was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M.
  • Daiwa Securities Group added most to AvalonBay Communities in Q2 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $172M.
  • Daiwa Securities Group fully exited Global X Cloud Computing ETF in Q2 2021, selling an estimated $29.5M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $14.8B portfolio in Q2 2021.
  • Daiwa Securities Group opened 31 new positions and closed 37 in Q2 2021.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.